Are You a Victim of Investment Losses with Applied Therapeutics, Inc. (NASDAQ:APLT)? New York, NY / Access Newswire / January 25, 2025 If you find yourself in a situation where you have suffered losses on your investment with Applied Therapeutics, Inc. (NASDAQ:APLT), you may be wondering about potential recovery options under the federal securities laws….
ArticleIFY 7-Day Meal Plan for Insulin Resistance: A Dietitian’s Guide Introduction Insulin is a hormone that helps your body cells receive the energy they need to function properly. Some of the food you eat is broken down into a sugar called glucose after meals, generating a natural rise in blood sugar levels. In response, the…
New York Law Firm Investigates Securities Claims Against Tungray Technologies Inc Overview Rosen Law Firm, a global investor rights law firm, has announced an investigation into potential securities claims against Tungray Technologies Inc (NASDAQ: TRSG). The investigation stems from allegations that Tungray Technologies may have provided misleading business information to investors. Potential Implications If you…
Investors Beware! Don’t Get Caught in the SeaStar Medical Holding Corporation Scandal Los Angeles, CA / August 20, 2024 / The Schall Law Firm has issued a warning to investors regarding a class action lawsuit against SeaStar Medical Holding Corporation. If you’ve invested in SeaStar (NASDAQ:ICU) between October 31, 2022, and March 26, 2024, you…
AILE Investors with Losses Encouraged to Contact the Firm Before Dec. 6, 2024 Deadline SAN FRANCISCO, CA / ACCESSWIRE / November 26, 2024 The price of iLearning Engines (NASDAQ:AILE) shares crashed over 30% lower on November 18, 2024 after announcing that (i) the company had placed CFO S. Farhan Naqvi on administrative leave effective immediately,…
Welcome to the Future: Isabella Bank Corporation Sees Increase in Fourth Quarter 2024 Net Income Breaking News: Isabella Bank Corporation Reports Strong Financial Results MT. PLEASANT, Mich., Jan. 30, 2025 /PRNewswire/ — Isabella Bank Corporation (OTCQX: ISBA) (the “Company” or “we”) reported fourth quarter 2024 net income of $4.0 million, or $0.54 per diluted share,…
Potential to Redefine Frontline AML Treatment: The Promise of Mipletamig Introduction Aptevo Therapeutics, a biotechnology company, is currently evaluating mipletamig as a potential frontline therapy for Acute Myeloid Leukemia (AML). This innovative treatment, in combination with standard of care medications, offers a multi-mechanism strategy that shows promise in improving patient outcomes. Favorable Early Results The…
Canada Launches Program to Poach Skilled Tech Workers from Silicon Valley Canada’s Tech Talent Recruitment Program Canada, with a history of seeking to lure away skilled foreign technology workers from Silicon Valley, on Tuesday announced a new program to poach such talent from the U.S. The nation to the north, with a population of 40…
